Boston Scientific CFO exercises RSUs, withholds shares

Boston Scientific EVP and CFO Jonathan Monson reported routine equity compensation activity involving restricted stock units.

Accepted by SEC EDGAR 07/02/2026 - 04:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Boston Scientific EVP and CFO Jonathan Monson reported routine equity compensation activity involving restricted stock units. He exercised 2,087 restricted stock units into 2,087 shares of common stock and, in a related tax-withholding disposition, 1,010 shares were withheld at a price of $43.06 per share to cover tax obligations. After these transactions, he directly holds 39,063 shares of common stock and 6,263 restricted stock units, which each represent a commitment by the company to issue one share of common stock in the future, with shares to be issued in four equal annual installments beginning on July 1, 2026.

Insider Trade Summary

2,087 shares exercised/converted

Exercise 3 txns

Insider Monson Jonathan

Role EVP and CFO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	2,087	$0.00	$0.00
Exercise	Common Stock	2,087	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,010	$43.06	$43K

Holdings After Transaction: Restricted Stock Units — 6,263 units (Direct); Common Stock — 39,063 shares (Direct)

Holdings Before and After: Restricted Stock Units, 8,350 to 6,263 units (Direct); Common Stock, 37,986 to 39,063 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. F2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant.

Key Figures

Tax-withheld shares: 1,010 shares at $43.06 RSUs exercised: 2,087 restricted stock units Common shares held: 39,063 shares +1 more

4 metrics

Tax-withheld shares 1,010 shares at $43.06 Shares withheld to satisfy tax liability on 2026-07-01

RSUs exercised 2,087 restricted stock units Converted into common stock on 2026-07-01

Common shares held 39,063 shares Direct ownership after transactions

RSUs outstanding 6,263 restricted stock units Units remaining after reported activity

Key Terms

Restricted Stock Units, tax-withholding disposition, derivative exercise/conversion, derivative security

4 terms

Restricted Stock Units financial

"security_title: "Restricted Stock Units" and footnote describing each unit as a commitment to issue one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for the F-code transaction"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

derivative exercise/conversion financial

"transaction_action: "derivative exercise/conversion" for the M-code transactions"

derivative security financial

"transaction_code_description references "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Boston Scientific (BSX) CFO Jonathan Monson report?

Jonathan Monson reported exercising 2,087 restricted stock units into common shares and a related tax-withholding disposition of 1,010 shares at $43.06 per share. These actions reflect routine equity compensation and tax settlement activity rather than open-market buying or selling.

How many Boston Scientific (BSX) shares does the CFO hold after this Form 4?

After the reported transactions, Jonathan Monson directly holds 39,063 shares of Boston Scientific common stock. He also holds 6,263 restricted stock units, which represent a commitment by the company to issue an equal number of common shares in the future.

What does the tax-withholding disposition in the Boston Scientific (BSX) Form 4 mean?

The tax-withholding disposition shows 1,010 shares withheld at $43.06 per share to satisfy tax liabilities arising from equity vesting. This is not an open-market sale but a mechanism for covering taxes owed when restricted stock units convert into common shares.

How do the restricted stock units reported for Boston Scientific (BSX) CFO vest and settle?

Each restricted stock unit represents a commitment to issue one Boston Scientific common share. According to the disclosure, shares will be issued to Jonathan Monson in four equal annual installments beginning July 1, 2026, aligning equity compensation with multi-year service and performance.

Did the Boston Scientific (BSX) CFO’s Form 4 show open-market buying or selling?

The filing did not show open-market purchases or sales. It reported an exercise of 2,087 restricted stock units into common stock and a related tax-withholding disposition of 1,010 shares, both standard components of equity compensation administration rather than discretionary market trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Monson Jonathan

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		M		2,087	A	$0.0000(1)	40,073	D
Common Stock	07/01/2026		F		1,010	D	$43.06	39,063	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/01/2026		M			2,087	(2)	07/01/2029(2)	Common Stock	2,087	$0.0000	6,263	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)